Fujirebio Gets FDA Clearance For First Lung-Cancer Management Assay
This article was originally published in The Gray Sheet
Executive Summary
Fujirebio Diagnostics says it has gained the first 510(k) clearance for a biomarker assay to help manage patients with lung cancer.